vs
GYRE THERAPEUTICS, INC.（GYRE）与RMR GROUP INC.（RMR）财务数据对比。点击上方公司名可切换其他公司
RMR GROUP INC.的季度营收约是GYRE THERAPEUTICS, INC.的1.8倍（$66.7M vs $37.2M），RMR GROUP INC.净利率更高（18.3% vs -3.7%，领先21.9%），RMR GROUP INC.同比增速更快（40.8% vs 33.4%）
GYRE Therapeutics是一家临床阶段生物制药企业，专注于开发针对难治性血液系统恶性肿瘤和实体瘤的新型靶向疗法，聚焦精准肿瘤学领域以满足未被满足的患者医疗需求，主要在北美地区开展业务。
RMR集团是总部位于美国的另类资产管理企业，核心业务聚焦不动产及相关投资，覆盖商业地产、住宅物业、基础设施等赛道，服务全球核心市场的机构投资者、高净值人士及零售客户。
GYRE vs RMR — 直观对比
营收规模更大
RMR
是对方的1.8倍
$37.2M
营收增速更快
RMR
高出7.3%
33.4%
净利率更高
RMR
高出21.9%
-3.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $37.2M | $66.7M |
| 净利润 | $-1.4M | $12.2M |
| 毛利率 | 95.3% | — |
| 营业利润率 | 0.3% | 48.1% |
| 净利率 | -3.7% | 18.3% |
| 营收同比 | 33.4% | 40.8% |
| 净利润同比 | -340.1% | 91.1% |
| 每股收益（稀释后） | $-0.01 | $0.71 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GYRERMR
| Q4 25 | $37.2M | $66.7M | ||
| Q3 25 | $30.6M | — | ||
| Q2 25 | $26.8M | — | ||
| Q1 25 | $22.1M | — | ||
| Q4 24 | $27.9M | — | ||
| Q3 24 | $25.5M | — | ||
| Q2 24 | $25.2M | — | ||
| Q1 24 | $27.2M | — |
净利润GYRERMR
| Q4 25 | $-1.4M | $12.2M | ||
| Q3 25 | $5.9M | — | ||
| Q2 25 | $1.6M | — | ||
| Q1 25 | $3.7M | — | ||
| Q4 24 | $569.0K | — | ||
| Q3 24 | $2.9M | — | ||
| Q2 24 | $4.5M | — | ||
| Q1 24 | $9.9M | — |
毛利率GYRERMR
| Q4 25 | 95.3% | — | ||
| Q3 25 | 94.7% | — | ||
| Q2 25 | 95.7% | — | ||
| Q1 25 | 95.9% | — | ||
| Q4 24 | 95.8% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 96.9% | — | ||
| Q1 24 | 96.4% | — |
营业利润率GYRERMR
| Q4 25 | 0.3% | 48.1% | ||
| Q3 25 | 22.7% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 10.3% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 16.6% | — | ||
| Q2 24 | 12.7% | — | ||
| Q1 24 | 29.7% | — |
净利率GYRERMR
| Q4 25 | -3.7% | 18.3% | ||
| Q3 25 | 19.4% | — | ||
| Q2 25 | 5.9% | — | ||
| Q1 25 | 16.9% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 18.0% | — | ||
| Q1 24 | 36.6% | — |
每股收益（稀释后）GYRERMR
| Q4 25 | $-0.01 | $0.71 | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.00 | — | ||
| Q1 25 | $0.00 | — | ||
| Q4 24 | $0.00 | — | ||
| Q3 24 | $0.01 | — | ||
| Q2 24 | $0.01 | — | ||
| Q1 24 | $0.03 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $52.4M | $49.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $106.0M | $232.7M |
| 总资产 | $166.1M | $687.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GYRERMR
| Q4 25 | $52.4M | $49.3M | ||
| Q3 25 | $60.0M | — | ||
| Q2 25 | $54.4M | — | ||
| Q1 25 | $29.9M | — | ||
| Q4 24 | $26.7M | — | ||
| Q3 24 | $25.1M | — | ||
| Q2 24 | $25.1M | — | ||
| Q1 24 | $37.4M | — |
股东权益GYRERMR
| Q4 25 | $106.0M | $232.7M | ||
| Q3 25 | $101.9M | — | ||
| Q2 25 | $92.0M | — | ||
| Q1 25 | $68.1M | — | ||
| Q4 24 | $63.3M | — | ||
| Q3 24 | $63.2M | — | ||
| Q2 24 | $60.4M | — | ||
| Q1 24 | $56.6M | — |
总资产GYRERMR
| Q4 25 | $166.1M | $687.1M | ||
| Q3 25 | $159.4M | — | ||
| Q2 25 | $152.6M | — | ||
| Q1 25 | $129.8M | — | ||
| Q4 24 | $125.4M | — | ||
| Q3 24 | $125.2M | — | ||
| Q2 24 | $120.9M | — | ||
| Q1 24 | $122.0M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.6M | $10.7M |
| 自由现金流经营现金流 - 资本支出 | $-5.8M | — |
| 自由现金流率自由现金流/营收 | -15.5% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | 0.88× |
| 过去12个月自由现金流最近4个季度 | $-180.0K | — |
8季度趋势，按日历期对齐
经营现金流GYRERMR
| Q4 25 | $-5.6M | $10.7M | ||
| Q3 25 | $4.7M | — | ||
| Q2 25 | $2.1M | — | ||
| Q1 25 | $-129.0K | — | ||
| Q4 24 | $-2.8M | — | ||
| Q3 24 | $1.7M | — | ||
| Q2 24 | $-5.5M | — | ||
| Q1 24 | $2.9M | — |
自由现金流GYRERMR
| Q4 25 | $-5.8M | — | ||
| Q3 25 | $4.0M | — | ||
| Q2 25 | $1.8M | — | ||
| Q1 25 | $-251.0K | — | ||
| Q4 24 | $-2.8M | — | ||
| Q3 24 | $1.0M | — | ||
| Q2 24 | $-6.9M | — | ||
| Q1 24 | $2.7M | — |
自由现金流率GYRERMR
| Q4 25 | -15.5% | — | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | -1.1% | — | ||
| Q4 24 | -10.1% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | -27.5% | — | ||
| Q1 24 | 9.8% | — |
资本支出强度GYRERMR
| Q4 25 | 0.4% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 5.8% | — | ||
| Q1 24 | 0.9% | — |
现金转化率GYRERMR
| Q4 25 | — | 0.88× | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 1.32× | — | ||
| Q1 25 | -0.03× | — | ||
| Q4 24 | -4.85× | — | ||
| Q3 24 | 0.60× | — | ||
| Q2 24 | -1.21× | — | ||
| Q1 24 | 0.29× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GYRE
暂无分部数据
RMR
| Management Service Incentive | $23.6M | 35% |
| Industrial Logistics Properties Trust | $15.1M | 23% |
| Managed Private Real Estate Capital | $11.1M | 17% |
| Office Properties Income Trust | $5.6M | 8% |
| Other Private Entities | $5.3M | 8% |
| RMR Residential | $3.4M | 5% |
| Sonesta International Hotels Corporation | $2.1M | 3% |
| Investment Advisory Management And Administrative Service | $1.2M | 2% |
